SJS Investment Consulting’s Agios Pharmaceuticals AGIO Stock Holding History

SJS Investment Consulting’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.86K	Buy	131 +130	+13,000%	+$3.94K	﹤0.01%	1398
2026 Q1	$34	Hold	1	–	–	﹤0.01%	2302
2025 Q4	$28	Sell	1 -1	-50%	-$35	﹤0.01%	2056
2025 Q3	$81	Buy	2 +1	+100%	+$38	﹤0.01%	1584
2025 Q2	$34	Sell	1 -1	-50%	-$30	﹤0.01%	1531
2025 Q1	$59	Sell	2 -7	-78%	-$232	﹤0.01%	1553
2024 Q4	$296	Buy	9 +3	+50%	+$141	﹤0.01%	1393
2024 Q3	$267	Buy	6 +3	+100%	+$136	﹤0.01%	1464
2024 Q2	$130	Hold	3	–	–	﹤0.01%	1563
2024 Q1	$88	Hold	3	–	–	﹤0.01%	1581
2023 Q4	$67	Hold	3	–	–	﹤0.01%	1578
2023 Q3	$75	Hold	3	–	–	﹤0.01%	1569
2023 Q2	$85	Buy	3 +1	+50%	+$25	﹤0.01%	1530
2023 Q1	$46	Sell	2 -1	-33%	-$27	﹤0.01%	1522
2022 Q4	$84	Buy	3 +2	+200%	+$56	﹤0.01%	1504
2022 Q3	$0	Buy	+1	New	+$27	﹤0.01%	1004
2022 Q1	$0	Buy	+1	New	+$31	﹤0.01%	674

Other funds holding AGIO

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SJS Investment Consulting's AGIO Position: Q2 2026 in Review

SJS Investment Consulting increased its Agios Pharmaceuticals (AGIO) stake by 13,000% in Q2 2026, buying an estimated $3.94K and bringing the position to 131 shares worth $4.86K. The position accounts for ﹤0.01% of the portfolio, ranked #1398.

SJS Investment Consulting first reported a position in AGIO in Q1 2022 and has held it in 17 quarters since. 38 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

SJS Investment Consulting held 131 shares of Agios Pharmaceuticals worth $4.86K as of Q2 2026.
SJS Investment Consulting bought 130 Agios Pharmaceuticals shares in Q2 2026, an estimated $3.94K.
Agios Pharmaceuticals made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1398 holding.
SJS Investment Consulting first reported a position in Agios Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
38 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.